ZD6126

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Carcinoma, Renal CellColorectal NeoplasmsKidney NeoplasmsMetastases, Neoplasm

Phase 2

Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.

TerminatedNCT00065117

AstraZenecaColorectal Neoplasms, Metastases, Neoplasm

Start: 2003-09-30End: 2004-02-29Target: 180Updated: 2011-01-26

Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)

SuspendedNCT00065572

AstraZenecaCarcinoma, Renal Cell, Kidney Neoplasms

Start: 2003-08-31End: 2004-02-29Updated: 2011-01-26